ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation

CONCLUSION: Hence, inhibition of ADAMTS13 could become a novel therapeutic strategy to manage aVWS in MCS device patients.PMID:36128768 | DOI:10.1111/jth.15889

Source: Thrombosis and Haemostasis - September 21, 2022 Category: Hematology Authors: Shannen J Deconinck Christoph Nix Svenja Barth Eveline Bennek-Sch öpping Antoine Rauch An-Sofie Schelpe Elien Roose Hendrik B Feys Inge Pareyn Aline Vandenbulcke Joshua Muia Christophe Vandenbriele Sophie Susen Bart Meyns Claudia Tersteeg Steven Jacobs S Source Type: research